Frequently bought together

Brand : XEFO

XEFO 8/MG 20/FC TAB

23.95

Sku : I-006849
Key features
XEFO 8MG 20TAB is a film‑coated tablet containing lornoxicam 8 mg. It reversibly inhibits COX‑1 and COX‑2, reducing prostaglandin synthesis to relieve pain, inflammation, and fever. It is indicated for short‑term treatment of acute mild to moderate pain and for symptomatic relief of pain and inflammation in osteoarthritis and rheumatoid arthritis. Supplied as film‑coated tablets in a pack of 20 tablets and available by prescription.
- Brand: XEFO
- Active Ingredient: LORNOXICAM 8mg
- Strength: 8mg
- Dosage Form: Film-coated tablet
- Pack Size: 20 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Analgesic
- Pharmacological Group: NSAIDs
- Drug Class: Oxicam derivative nonsteroidal anti‑inflammatory drug (NSAID); non‑selective cyclooxygenase (COX‑1/COX‑2) inhibitor.
- Manufacturer: TAKEDA
- Country of Origin: Germany
- SFDA Registration No.: 0306257541
- Shelf Life: 36 months
- Storage: store below 25°c
- Pain Type: Joint/Muscular
- Nsaid: Yes
- Opioid: No

Frequently bought together

Description

Specification

Indications

Approved Uses

Short‑term treatment of acute mild to moderate pain; symptomatic relief of pain and inflammation in osteoarthritis; symptomatic relief of pain and inflammation in rheumatoid arthritis.

Dosage & Administration

Dosing by Condition

Acute pain: 8-16 mg/day in 2-3 divided doses (max 16 mg/day). Osteoarthritis/Rheumatoid arthritis: usually 12 mg/day in 2-3 divided doses; may increase up to 16 mg/day (max 16 mg/day).

Initial Dose

8-16 mg daily for pain; 12 mg daily for arthritis.

Maintenance Dose

8mg twice daily (16mg/day)

Maximum Dose

16 mg daily (oral).

Pharmacology

Mechanism of Action

Reversibly inhibits COX‑1 and COX‑2, decreasing prostaglandin synthesis and thereby reducing pain, inflammation, and fever.

Duration of Effect

Approximately 4 hours (standard release 8 mg dose)

Half-Life

Terminal elimination half-life is approximately 3-5 hours (commonly cited around 4 hours).

Product Information

Available Dosage Forms

For this SFDA-registered product: oral film‑coated tablet (8 mg).

Composition per Dose

Each film-coated tablet: 8mg lornoxicam

Pain Type

Joint/Muscular

Nsaid

Yes

Opioid

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
Any discrepancy between the information provided and the product's package insert or SFDA guidelines
Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.